Most companies meet the phrase “FDA compliance” on a bad day. An investigator leaves a Form 483 on the table after a plant walkthrough, or a buyer’s diligence checklist asks for records nobody kept, and the abstract idea suddenly has teeth. So here is the working definition, and then the part that actually decides outcomes. FDA compliance is meeting the Food and Drug Administration’s requirements for how a product gets made, tested, labeled, registered, and tracked. Writing that sentence is easy. Proving it on the morning an inspector asks is the whole job.
The agency can ask in several ways. A facility inspection. A records request. A look at your entry data when goods hit the border. A sample pulled off a retail shelf and sent to a lab. When the proof is sitting where it should be, the visit is a Tuesday. When it is not, the same facts turn into a Warning Letter, an import refusal, a seizure, or an injunction that idles a line.
FDA compliance, in one sentence: meeting every FDA requirement that applies to your product – safety, manufacturing practice, labeling, registration, recordkeeping – and being able to prove it the moment the agency asks.
FDA Compliance Is Not FDA Approval
People swap these two terms constantly, and the mix-up causes real problems. They answer different questions. Approval is a yes the agency gives before a product can be sold, and only a few categories ever need it: new drugs, certain medical devices, some food additives. Compliance is the ongoing question of whether you are following the rules that bind your product right now.
Here is where it bites. A dietary supplement never gets “approved” by FDA. It still has to comply with the rules for supplement manufacturing, labeling, and claims. So when a supplement label announces the product is “FDA approved,” it is not only inaccurate. It can be the misbranding violation. That is usually the first line I tell a client to delete, before we ever get to whether the rest of the label reads well.
Who FDA Regulates, and Where the Line Runs
The reach is broad. Human and animal drugs, biologics, devices, most of the food supply, supplements, cosmetics, tobacco, even electronics that emit radiation. On the food side alone, FDA oversees roughly 80 percent of what ends up on American tables.
The other 20 percent is where companies trip. Meat, poultry, and processed egg products belong to the U.S. Department of Agriculture, not FDA. A cheese pizza is FDA’s problem. Drop pepperoni on it and, past a threshold, the same product can answer to USDA instead, with different inspectors and a different set of penalties. That sounds like a technicality until it decides which agency shows up at your door. If your product sits anywhere near that boundary, work out how FDA and USDA divide jurisdiction before you do anything else.
The Laws That Sit Underneath Compliance
It all starts with the Federal Food, Drug, and Cosmetic Act (FDCA). That is the statute that bans adulterated and misbranded products and hands FDA the bulk of its inspection and enforcement muscle. From there, what binds you depends on what you make. Food facilities answer mostly to FSMA. Supplement companies answer to DSHEA and the supplement manufacturing rules. Drug, device, cosmetic, and tobacco makers each carry their own additions on top of the base.
FSMA and Preventive Controls
FSMA, the FDA Food Safety Modernization Act, pushed federal food-safety law toward heading problems off rather than reacting to outbreaks. For most facilities that means a written food safety plan: figure out the hazards, set controls, watch those controls, write it all down. The preventive-controls requirements live in 21 CFR Part 117.
Records are the quiet failure point. A plant can be running its controls perfectly well and still look careless if the paperwork is thin, because an investigator can only credit what is documented. I have watched a genuinely clean operation struggle through an inspection purely on a filing gap. The control was there. The proof was not.
DSHEA and Dietary Supplements
Supplements run on their own track, set by the Dietary Supplement Health and Education Act of 1994. No premarket approval the way a drug gets reviewed. What they do owe: the supplement manufacturing rules in 21 CFR Part 111, honest substantiation behind any claim, and a hard line against disease claims that would turn the product into an unapproved drug in the agency’s eyes. That after-the-fact posture is exactly why FDA reads supplement labels and batch records so closely once the product is already selling.
The Violations That Show Up Again and Again
None of the usual problems are exotic, which is part of why they irritate the agency when they repeat. They cluster in a handful of places:
- Labeling errors. A nutrition panel that does not match the formula, an allergen left undeclared, an ingredient statement that drifted from what is actually in the bottle.
- Claims that go too far, usually when the wording names a disease or promises a treatment effect and quietly reclassifies a food or supplement as a drug.
- Manufacturing-practice gaps in sanitation, pest control, batch records, or any step the company cannot show it verified.
- Registration that lapsed when nobody was watching the calendar, or a device that was supposed to be listed and never was.
- Thin records. This one stings, because the agency tends to read an undocumented control as a control you cannot prove you had.
Most of these never wait for a customer complaint. They turn up mid-inspection. The cheapest time to deal with them is months earlier, which is why it helps to know the common compliance missteps that catch FDA’s attention, and to settle food labeling requirements before a product ever ships.
From a 483 to an Injunction: How Enforcement Climbs
Enforcement is a staircase, and knowing which step you are on tells you how hard to run. What you do at each step changes whether the matter quietly ends or keeps climbing.
The Form 483
An inspection that surfaces problems usually closes with a Form 483, the investigator’s written list of conditions that may break the FDCA. It is not a verdict and it is not a fine. Think of it as the agency telling you what it saw and waiting to see how you answer.
That answer is where companies leave value on the table. Respond inside 15 working days and FDA weighs your corrective plan before it decides whether to escalate. A response that names the fix, the person who owns it, and the date it will be done lands very differently from a paragraph of reassurance. Investigators have read the reassurance version a thousand times.
Warning Letters
When the agency decides the problems are serious enough for a formal shot across the bow, it issues a Warning Letter. It says, on the record, that FDA has found violations and expects them fixed. These are public. Your customers can read them, so can your competitors, and so can the plaintiffs’ bar looking for a hook.
Past the letter, the tools stop being polite: import detention and refusal, recalls where the statute reaches, seizure, a consent decree, an injunction filed in federal court. Any of that history, the 483s and the letters, is searchable through FDA’s compliance and enforcement resources.
Checking a Company’s FDA Record
A lot of this is public, and reading it is ordinary diligence before you sign with a supplier, buy a company, or size up a competitor. The Warning Letter database, the FDA Data Dashboard, recall notices, the Import Alert lists, all of them search by company name. One stray entry is usually noise. A pattern is not. Repeated observations, a corrective action that never closed, an open Warning Letter, those point to operating risk that will not appear anywhere in a pitch deck, and the buyer almost always wants it on the table before the deal does.
A Compliance Program That Survives the Visit
The programs that hold up under inspection tend to look the same. Written down. Actually followed on the floor. Backed by records that exist before anyone asks. The pieces carry across food and supplement operations:
- Match the rules to the product first. Know which statute, which CFR part, which registration and label and record rules apply before you build a single control around them.
- Put the plan on paper and keep it breathing. A FSMA food safety plan, a manufacturing-practice program, a supplier file, a label-review step, whatever the product needs.
- Train the people running it, and keep the training records, because “we covered that in a meeting once” is not a record.
- Capture the proof as the work happens, not the night before an audit.
- Audit yourself on a schedule so you are the one finding the gaps, not the investigator.
Done this way, compliance is the cheap path. A recall or a consent decree can cost many times what the routine controls would have, and that math rarely surprises anyone after the fact.
When It Stops Being Operational and Becomes Legal
Most days, compliance is just operations done carefully. It crosses into legal territory at specific moments: a serious 483, a Warning Letter, an import detention, a recall call, or an FDA request that smells like it is heading toward a criminal referral. At that point your response is a legal document with legal weight, and it should be treated that way.
These questions also rarely stay inside one agency. They run from importing food under FDA rules straight into the parallel duties under USDA and FSIS oversight for meat and poultry. When the exposure climbs, getting FDA compliance counsel involved before the response deadline runs is usually what stops a citation from hardening into an enforcement action. OFW Law’s food and agriculture practice works on 483 and Warning Letter responses, recalls, and enforcement defense across FDA-regulated industries.
Frequently Asked Questions About FDA Compliance
What does “FDA compliant” mean compared with “FDA approved”?
FDA approved means the agency made a premarket decision to allow a product, which only happens for categories like new drugs and certain devices. FDA compliant means the product meets the FDA rules that govern its category, including safety, labeling, manufacturing, and recordkeeping, whether or not approval was ever part of the picture. Most foods, supplements, and cosmetics are never approved, and they still have to be compliant.
What penalties can FDA non-compliance trigger?
They scale with how bad the violation is. The range runs from a Form 483 and a Warning Letter up through import refusals, seizures, recalls, civil monetary penalties, consent decrees, and injunctions that can stop production outright. Where there is fraud or a knowing violation, the agency can send it for criminal prosecution.
Who actually inspects facilities for FDA compliance?
FDA investigators out of the agency’s field offices, both in the United States and abroad. At the border, FDA works alongside Customs and Border Protection. Some food-facility inspections are handled by state agencies under contract with FDA, so the badge at the door is not always federal.
Where can I check a company’s FDA compliance history?
Start with the Warning Letter database, the FDA Data Dashboard, recall announcements, and the Import Alert lists, all searchable by company name. A run of repeat observations or an open Warning Letter is the kind of signal worth catching before you commit to a supplier or close an acquisition.
Does FDA compliance apply to small businesses?
It does, though some rules phase in by size or carve out the smallest operations. A small food facility might qualify for modified FSMA requirements, for instance. What no business gets to skip is the basic bar against adulterated or misbranded products. Check which thresholds and exemptions fit your specific operation rather than assuming small means exempt.
How long does a company have to respond to an FDA Form 483?
Fifteen working days, if you want FDA to weigh your response before it decides on further action. A reply that pairs each observation with a specific fix and a completion date carries far more weight than a general or late one.
This article is for informational purposes only and does not constitute legal advice. Consult a qualified attorney about your specific situation. For questions about FDA compliance, contact the OFW Law team.
Received a Form 483 or Warning Letter?
OFW Law helps FDA-regulated companies respond to inspections, Warning Letters, recalls, and enforcement actions. Connect with our team about your FDA compliance question.
